Product Name: Daclatasvir dihydrochloride
 CAT#: A-9002

Request Daclatasvir dihydrochloride
 Synonym: BMS790052; BMS 790052; BMS-790052; EBP883; EBP 883; EBP-883; trade name Daklinza. PubchemCID 25154714 ,

Daclatasvir dihydrochloride Chemical Structure
Daclatasvir dihydrochloridechemical structure

5 stars, based on 1836 reviews

IUPAC/Chemical name:

Price of Daclatasvir dihydrochloride

We offer a substantial discount on larger orders,
please inquire via sales@activebiochem.com
or Fax: 1-201-884-1288 (USA Fax#)


Biological Activity
Daclatasvir (USAN), also known as BMS-790052 and EBP-883 (trade name Daklinza), is NS5A inhibitor and a drug for the treatment of hepatitis C (HCV). It is was developed by Bristol-Myers Squibb and was approved in Europe on 22 August 2014. Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA. Daclatasvir has been tested in combination regimens with pegylated interferon and ribavirin, as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir.
Technical Data

Purity: >99%
CAS#:1009119-65-6 (2HCl salt); 1009119-64-5 (free base)
Chemical Formula:C40H50N8O6
Molecular Weight:738.88
Daclatasvir dihydrochloride MSDSDaclatasvir dihydrochloride CoA

IUPAC/Chemical name:methyl N-[(2S)-1-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl]phenyl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate dihydrochloride
Canonical SMILES:O=C(OC)N[C@@H](C(C)C)C(N1[C@H](C2=NC=C(C3=CC=C(C4=CC=C(C5=CN=C([C@H]6N(C([C@@H](NC(OC)=O)C(C)C)=O)CCC6)N5)C=C4)C=C3)N2)CCC1)=O.[H]Cl.[H]Cl
Reference





Purchase(buy) Daclatasvir dihydrochloride at Active Biochem and the United State(U.S.), Germany, Japan, France,United Kingdom(UK),Switzerland, Australia distributors.